News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
186,678 Results
Type
Article (18881)
Company Profile (21)
Press Release (167776)
Multimedia
Podcasts (17)
Webinars (4)
Section
Business (49326)
Career Advice (239)
Deals (7041)
Drug Delivery (27)
Drug Development (26572)
Employer Resources (37)
FDA (4248)
Job Trends (4714)
News (86685)
Policy (9153)
Tag
Academia (1825)
Accelerated approval (1)
Adcomms (13)
Allergies (20)
Alliances (15696)
ALS (22)
Alzheimer's disease (577)
Antibody-drug conjugate (ADC) (28)
Approvals (4279)
Artificial intelligence (81)
Autoimmune disease (3)
Automation (4)
Bankruptcy (52)
Best Places to Work (4150)
BIOSECURE Act (15)
Biosimilars (12)
Biotechnology (14)
Bladder cancer (36)
Brain cancer (10)
Breast cancer (92)
Cancer (808)
Cardiovascular disease (39)
Career advice (225)
Career pathing (4)
CAR-T (52)
Cell therapy (133)
Cervical cancer (12)
Clinical research (20121)
Collaboration (269)
Compensation (23)
Complete response letters (3)
COVID-19 (2312)
CRISPR (15)
C-suite (78)
Cystic fibrosis (30)
Data (705)
Depression (5)
Diabetes (44)
Diagnostics (1874)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (34)
Drug pricing (24)
Drug shortages (3)
Duchenne muscular dystrophy (18)
Earnings (12558)
Editorial (16)
Employer branding (4)
Employer resources (31)
Events (23774)
Executive appointments (182)
FDA (4657)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (315)
Gene editing (31)
Generative AI (4)
Gene therapy (120)
GLP-1 (159)
Government (2461)
Grass and pollen (2)
Guidances (15)
Healthcare (6000)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (25)
Indications (4)
Infectious disease (2436)
Inflammatory bowel disease (48)
Inflation Reduction Act (3)
Influenza (48)
Intellectual property (18)
Interviews (20)
IPO (3445)
IRA (16)
Job creations (772)
Job search strategy (215)
Kidney cancer (6)
Labor market (8)
Layoffs (106)
Leadership (1)
Legal (1311)
Liver cancer (23)
Lung cancer (118)
Lymphoma (58)
Machine learning (3)
Management (13)
Manufacturing (98)
MASH (11)
Medical device (2750)
Medtech (2750)
Mergers & acquisitions (3759)
Metabolic disorders (99)
Multiple sclerosis (30)
NASH (4)
Neurodegenerative disease (15)
Neuropsychiatric disorders (3)
Neuroscience (714)
NextGen: Class of 2025 (1780)
Non-profit (2037)
Now hiring (7)
Obesity (41)
Opinion (70)
Ovarian cancer (35)
Pain (23)
Pancreatic cancer (22)
Parkinson's disease (36)
Partnered (7)
Patents (49)
Patient recruitment (30)
Peanut (13)
People (17839)
Pharmaceutical (10)
Phase I (6805)
Phase II (8936)
Phase III (6565)
Pipeline (325)
Policy (78)
Postmarket research (849)
Preclinical (2951)
Press Release (32)
Prostate cancer (30)
Psychedelics (13)
Radiopharmaceuticals (55)
Rare diseases (111)
Real estate (1581)
Recruiting (15)
Regulatory (6188)
Reports (14)
Research institute (1962)
Resumes & cover letters (18)
Rett syndrome (1)
RNA editing (3)
RSV (50)
Schizophrenia (11)
Series A (44)
Series B (19)
Service/supplier (1)
Sickle cell disease (22)
Spinal muscular atrophy (26)
Sponsored (5)
Startups (1235)
Stomach cancer (3)
Supply chain (25)
Tariffs (12)
The Weekly (16)
Vaccines (806)
Venture capitalists (15)
Weight loss (26)
Women's health (3)
Worklife (3)
Date
Today (35)
Last 7 days (219)
Last 30 days (688)
Last 365 days (8799)
2025 (2784)
2024 (9503)
2023 (11353)
2022 (16304)
2021 (18284)
2020 (16451)
2019 (12845)
2018 (9592)
2017 (8761)
2016 (8846)
2015 (10417)
2014 (7882)
2013 (6423)
2012 (6632)
2011 (6948)
2010 (6153)
Location
Africa (289)
Alabama (33)
Alaska (4)
Arizona (54)
Arkansas (3)
Asia (12038)
Australia (2440)
California (1322)
Canada (461)
China (107)
Colorado (64)
Connecticut (68)
Delaware (52)
Europe (26046)
Florida (250)
Georgia (58)
Idaho (12)
Illinois (133)
India (9)
Indiana (64)
Iowa (1)
Japan (60)
Kansas (28)
Kentucky (12)
Louisiana (1)
Maine (10)
Maryland (397)
Massachusetts (987)
Michigan (35)
Minnesota (73)
Missouri (27)
Montana (13)
Nebraska (6)
Nevada (5)
New Hampshire (13)
New Jersey (671)
New Mexico (7)
New York (543)
North Carolina (198)
North Dakota (8)
Northern California (569)
Ohio (53)
Oklahoma (5)
Oregon (8)
Pennsylvania (353)
Puerto Rico (2)
Rhode Island (10)
South America (307)
South Carolina (6)
Southern California (511)
Tennessee (24)
Texas (255)
United States (5961)
Utah (38)
Virginia (35)
Washington D.C. (34)
Washington State (151)
West Virginia (1)
Wisconsin (11)
186,678 Results for "sabin vaccine institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Marburg Vaccine in Uganda
The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate against the lethal Marburg virus.
October 19, 2023
·
6 min read
Business
Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin’s Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in the National Academy of Sciences building in Washington D.C.
April 19, 2024
·
8 min read
Press Releases
Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine
July 15, 2024
·
6 min read
Press Releases
Infectious Disease Expert Kelly Warfield Named Sabin’s New R&D President
August 20, 2024
·
4 min read
BioCapital
Sabin Vaccine Institute Receives $35 Million from BARDA with Potential of up to $214 Million for Ebola Sudan and Marburg Vaccines
The Sabin Vaccine Institute today announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded Sabin a multi-year contract with funding potential for up to $214 million to advance the development and production of single-dose vaccine candidates for Ebola Sudan and Marburg virus diseases.
January 12, 2023
·
4 min read
Business
Vaccine R&D Leader Kathrin Jansen and Immunologist Kizzmekia Corbett Awarded Sabin’s Gold Medal and Rising Star Respectively
The Sabin Vaccine Institute honored two extraordinary scientists for their breakthrough vaccine research that changed the course of the COVID-19 pandemic, advanced public health, and saved countless lives.
December 7, 2022
·
4 min read
Business
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
STAAR Surgical Company, a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses for myopia, astigmatism and presbyopia, announced Nancy Sabin has been named Chief Marketing Officer and Nathaniel Sisitsky has been named General Counsel.
May 1, 2024
·
4 min read
Policy
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and less affordable,” according to vaccine expert Paul Offit. It could also further complicate the picture for companies like Novavax.
May 1, 2025
·
3 min read
·
Heather McKenzie
EverGlade Consulting Helps Sabin Vaccine Institute Secure up to $214 Million in BARDA Funding to Develop and Procure Ebola Sudan and Marburg Vaccines
EverGlade Consulting (“EverGlade”), a national consulting firm, has helped Sabin Vaccine Institute successfully secure up to $214 million in funding through a contract with the Biomedical Advanced Research and Development Authority (“BARDA”) to advance the development and production of single-dose vaccine candidates for Ebola Sudan and Marburg virus diseases.
January 25, 2023
·
2 min read
BioMidwest
PharmaJet Vaccine Delivery Featured at Sabin Vaccine Institute Conference
PharmaJet® announced that their poster will be presented on March 1-3, 2022 at the Vaccination Acceptance Research Network conference, sponsored by the Sabin Vaccine Institute.
March 1, 2022
·
4 min read
1 of 18,668
Next
